Target Name: POU5F1P3
NCBI ID: G642559
Review Report on POU5F1P3 Target / Biomarker Content of Review Report on POU5F1P3 Target / Biomarker
POU5F1P3
Other Name(s): Oct-3 | POU5F1L | OTF-3 | OCT3 | OTF3L | OCT4-pg3 | POU5F1 | POU5FLC12 | POU class 5 homeobox 1 pseudogene 3 | OTF3 | Oct-4 | OCT4

POU5F1P3: A Potential Drug Target and Biomarker

POU5F1P3, also known as POU5F1 gene, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the POU5F1 gene family, which is known for its role in regulating cellular processes such as cell adhesion, migration, and survival. The POU5F1P3 protein has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The POU5F1P3 gene was first identified in the late 1990s by researchers using transcriptional analysis of RNA from various tissues. The gene was found to be highly expressed in the brain, heart, and kidneys, and its expression was also increased in various diseases, including neurodegenerative diseases, cancer, and autoimmune disorders.

One of the key functions of the POU5F1P3 protein is its role in cell adhesion and migration. POU5F1P3 is a member of the cadherin subfamily, which is known for its role in cell-cell adhesion and migration. Cadherins are a family of transmembrane proteins that are involved in various signaling pathways, including cell division, growth, and survival. POU5F1P3 is thought to play a key role in the regulation of cadherin signaling in various tissues of the body.

In neurodegenerative diseases, POU5F1P3 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neurodegeneration. POU5F1P3 has been shown to be involved in the regulation of neurodegenerate disease by various mechanisms, including the regulation of cell adhesion and migration, and the modulation of cellular signaling pathways.

In addition to its role in neurodegenerative diseases, POU5F1P3 has also been shown to be involved in the regulation of cancer. Cancer is a complex disease that is characterized by the rapid and uncontrolled growth of cells. POU5F1P3 has been shown to be involved in the regulation of cell growth and survival in various tissues of the body, including the regulation of cell division and the modulation of cellular signaling pathways. This suggests that POU5F1P3 may be a potential drug target for cancer.

POU5F1P3 has also been identified as a potential biomarker for various diseases, including neurodegenerative diseases, cancer, and autoimmune disorders. The expression of POU5F1P3 has been shown to be increased in various tissues of the body, including the brain, heart, and kidneys, and its expression has been associated with the development and progression of various diseases. For example, POU5F1P3 has been shown to be increased in the brains of individuals with Alzheimer's disease, and its expression has also been associated with the development of other neurodegenerative diseases.

In addition to its potential clinical applications, POU5F1P3 also has potential as a research tool for the study of various biological processes, including cell adhesion, migration, and signaling pathways. The POU5F1P3 gene has been shown to be involved in the regulation of numerous cellular processes, including cell adhesion and migration, and its expression has been associated with the development and progression of various diseases. This suggests that POU5F1P3 may be a valuable tool for the study of these biological processes and their role in the development and progression of disease.

In conclusion, POU5F1P3 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in

Protein Name: POU Class 5 Homeobox 1 Pseudogene 3

The "POU5F1P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POU5F1P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

POU5F1P4 | POU5F1P5 | POU5F2 | POU6F1 | POU6F2 | PP12613 | PP2D1 | PP7080 | PPA1 | PPA2 | PPAN | PPAN-P2RY11 | PPARA | PPARD | PPARG | PPARGC1A | PPARGC1B | PPAT | PPATP1 | PPBP | PPBPP2 | PPCDC | PPCS | PPDPF | PPDPFL | PPEF1 | PPEF2 | PPFIA1 | PPFIA2 | PPFIA3 | PPFIA4 | PPFIBP1 | PPFIBP2 | PPHLN1 | PPIA | PPIAL4A | PPIAL4D | PPIAL4E | PPIAL4F | PPIAL4G | PPIAL4H | PPIAP19 | PPIAP21 | PPIAP22 | PPIAP29 | PPIAP30 | PPIAP35 | PPIAP43 | PPIAP45 | PPIAP46 | PPIAP51 | PPIAP54 | PPIAP59 | PPIAP66 | PPIAP7 | PPIAP74 | PPIAP8 | PPIAP80 | PPIAP9 | PPIB | PPIC | PPID | PPIE | PPIEL | PPIF | PPIG | PPIH | PPIL1 | PPIL2 | PPIL3 | PPIL4 | PPIL6 | PPIP5K1 | PPIP5K2 | PPL | PPM1A | PPM1B | PPM1D | PPM1E | PPM1F | PPM1G | PPM1H | PPM1J | PPM1K | PPM1K-DT | PPM1L | PPM1M | PPM1N | PPME1 | PPOX | PPP1CA | PPP1CB | PPP1CC | PPP1R10 | PPP1R11 | PPP1R12A | PPP1R12A-AS1 | PPP1R12B | PPP1R12C | PPP1R13B